New tests for Lyme disease

Clinical Microbiology Newsletter

Volumn 25, Issue 19, 2003, Pages 145-149

  Tilton, Richard C ^a  

^a Medical Diagnostic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; LYME DISEASE VACCINE; OUTER SURFACE PROTEIN A; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACTERIUM IDENTIFICATION; BORRELIA BURGDORFERI; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; HUMAN; IMMUNE RESPONSE; INTERMETHOD COMPARISON; LYME DISEASE; NONHUMAN; OPSONIZATION; RELIABILITY; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0141705289     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(03)80050-8     Document Type: Article

References (41)

1. Hellerstrom, S. 1950. Erythema migrans afzelius with meningitis. South. Med. J. 43:330-335.
2. Steere, A.C. et al. 1977. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 20:7-17.
3. Burgdorfer, W. et al. 1982. Lyme disease - a tickborne spirochetosis? Science 216:1317-1319.
4. Benach, J.L. et al. 1983. Spirochetes isolated from the blood of two patients with Lyme disease. N. Engl. J. Med. 308:740-742.
5. Steere, A.C. et al. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308:733-740.
6. Bakken, L.L et al. 1992. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 268:891-895.
7. Fister, R.D. et al. 1989. Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum. J. Clin. Microbiol. 27:2834-2837.
8. Centers for Disease Control and Prevention. 1995. Recommendations for test performance and interpretation from the 2nd National Conference on Serological Diagnosis of Lyme Disease. Morb. Mortal. Wkly. Rep. 44:590-591.
9. Magnarelli, L.A. et al. 1996. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J. Clin. Microbiol. 34:237-240.
10. Agger, W.A. and K.L. Case. 1997. Clinical comparison of borreliacidal antibody test with indirect immunofluorescence and enzyme-linked immunosorbent assays for diagnosis of Lyme disease. Mayo Clin. Proc. 72:510-514.
11. Padilla, M. et al. 1996. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine. J. Infect. Dis. 174:739-746.
12. Luke, C.J. et al. 2000. Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or both. J. Infect. Dis. 181:1062-1068.
13. Simon, M.M. et al. 1991. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J. Infect. Dis. 164:123-132.
14. Steere, A.C. et al. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant: Lyme Disease Vaccine Study Group. N. Engl. J. Med. 339:209-215.
15. Sigal, L.H. et al. 1998. A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein A to prevent Lyme disease: Recombinant Outer Surface Protein A Vaccine Study Consortium. N. Engl. J. Med. 339:216-222.
16. Callister, S.M. et al. 1993. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J. Infect. Dis. 167:158-164.
17. Callister, S.M. et al. 1996. Sensitivity and specificity of the borreliacidal antibody test during early Lyme disease: a "gold standard"? Clin. Diagn. Lab. Immunol. 3:399-402.
18. Rouselle, J.C. et al. 1998. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi. J. Infect. Dis. 178:733-741.
19. Hoffman, H. 1996. Lyme borreliosis - problems of serological diagnosis. Infection 24:470-472.
20. Fikrig, E.A. et al. 1992. Serological diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin. J. Infect. Dis. 165:1127-1132.
21. Gerber, M.A. et al. 1995. Recombinant outer surface protein C ELISA for the diagnosis of early Lyme disease. J. Infect. Dis. 171:724-727.
22. Oksi, J. et al. 1995. Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and p39 protein in patients with PCR or culture-proven late Lyme disease. J. Clin. Microbiol. 33:2260-2264.
23. Rauer, S. et al. 1995. Establishment of enzyme linked immunosorbent assay using purified recombinant 83-kilo-dalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelli for serodiagnosis of Lyme disease. J. Clin. Microbiol. 33:2596-2600.
24. Jwang, B. et al. 1995. The hook protein of Borrelia burgdorferi encoded by the flg E gene, is serologically recognized in Lyme disease. Clin. Diagn. Lab. Immunol. 2:609-615.
25. Gilmore, R.D. et al. 1999. The Borrelia burgdorferi 37-kilodalton immunoblot band (p37) used in serodiagnosis of early Lyme disease is the flA gene product. J. Clin. Microbiol. 37:548-552.
26. Liang, F.T. et al. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
27. Lawrenz, M.B. et al. 1999. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37:3997-4004.
28. Magnarelli, L.A. et al. 2002. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme linked immunosorbent assays for Lyme borreliosis. J. Med. Microbiol. 51:649-655.
29. Wieneke, C.A. et al. 2000. Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early Lyme borreliosis from OspA vaccination. J. Clin. Microbiol. 38:313-317.
30. Liang, F.T. et al. 2000. Antigenic conservation of an immunodominant variable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J. Infect. Dis. 182:1455-1462.
31. Mathieson, M.J. et al. 1998, Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J. Clin. Microbiol. 36:3474-3479.
32. Mathieson, M.J. et al. 1998. The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif. Infect. Immun. 66:4073-4079.
33. Bacon, R.M. et al. 2003. Serodiagnosis of Lyme disease by kinetic enzymelinked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2 tiered testing using whole cell lysates. J. Infect. Dis. 187:1187-1199.
34. Molloy, P.J. et al. 2000. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A Lyme disease vaccination. Clin. Infect. Dis. 31:42-47.
35. Fawcett, P.T. et al. 2001. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis. Clin. Diagn. Lab. Immunol. 8:79-84.
36. Craft, J.E., R.L. Grodzicki, and A.C. Steere. 1984. Antibody response in Lyme disease: evaluation of diagnostic tests. J. Infect. Dis. 149:789-795.
37. Philipp, M.T. et al. 2001. Antibody response to IR6, a conserved region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J. Infect. Dis. 184:870-878.
38. Peltomaa, M., G. McHugh, and A.C. Steere. 2003. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful treatment of Lyme disease. J. Infect. Dis. 187: 1178-1186.
39. Schutzer, S.E. et al. 1990. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 335:312-315.
40. Brunner, M. and L.H. Sigal. 2000. Immune complexes from serum of patients with Lyme disease contain Borrelia burgdorferi antigen and antigen-specific antibodies. Potential use for improved testing. J. Infect. Dis. 182:534-539.
41. Schutzer, S.E. et al. 1999. Borrelia burgdorferi-specific immune complexes in acute Lyme disease. JAMA 282:1942-1946.